Selected research
Market Structure
Global Cell Immunotherapy Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cell Immunotherapy Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Cell Immunotherapy Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cell Immunotherapy Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell Immunotherapy Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cell Immunotherapy Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cell Immunotherapy Platform include Kite Pharma, Novartis, Bristol Myers Squibb, Gilead Sciences, Bluebird Bio, Celyad Oncology, Autolus Therapeutics, Legend Biotech and Celltrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Cell Immunotherapy Platform market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell Immunotherapy Platform and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell Immunotherapy Platform revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell Immunotherapy Platform market size, projected growth trends, production technologies, key applications, and end-use industries.
Cell Immunotherapy Platform Segment by Company
Kite Pharma
Novartis
Bristol Myers Squibb
Gilead Sciences
Bluebird Bio
Celyad Oncology
Autolus Therapeutics
Legend Biotech
Celltrion
Cell Immunotherapy Platform Segment by Type
Autologous Immune Cell Therapy
Allogeneic Immune Cell Therapy
Cell Immunotherapy Platform Segment by Application
Immunotherapy Industry
Biopharmaceutical Industry
Others
Cell Immunotherapy Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Immunotherapy Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Immunotherapy Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Immunotherapy Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell Immunotherapy Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Immunotherapy Platform industry.
Chapter 3: Detailed analysis of Cell Immunotherapy Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Immunotherapy Platformrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Autologous Immune Cell Therapy
- Allogeneic Immune Cell Therapy
Applications
- Immunotherapy Industry
- Biopharmaceutical Industry
- Others
Companies covered
- Kite Pharma
- Novartis
- Bristol Myers Squibb
- Gilead Sciences
- Bluebird Bio
- Celyad Oncology
- Autolus Therapeutics
- Legend Biotech
- Celltrion
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Cell Immunotherapy Platform Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Autologous Immune Cell Therapy
- 1.2.3 Allogeneic Immune Cell Therapy
- 1.3 Market Analysis by Application
- 1.3.1 Global Cell Immunotherapy Platform Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Immunotherapy Industry
- 1.3.3 Biopharmaceutical Industry
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Cell Immunotherapy Platform Growth Trends by Region
- 1.5.1 Global Cell Immunotherapy Platform Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Cell Immunotherapy Platform Market Size by Region (2021-2026)
- 1.5.3 Cell Immunotherapy Platform Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Cell Immunotherapy Platform Market Dynamics
- 2.1 Cell Immunotherapy Platform Industry Trends
- 2.2 Cell Immunotherapy Platform Industry Drivers
- 2.3 Cell Immunotherapy Platform Industry Opportunities and Challenges
- 2.4 Cell Immunotherapy Platform Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Cell Immunotherapy Platform Revenue by Company (2021-2026)
- 3.2 Global Cell Immunotherapy Platform Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Cell Immunotherapy Platform Key Company Head office and Area Served
- 3.4 Global Cell Immunotherapy Platform Company, Product Type & Application
- 3.5 Global Cell Immunotherapy Platform Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Cell Immunotherapy Platform Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Cell Immunotherapy Platform Players Market Share by Revenue in 2025
- 3.6.3 2025 Cell Immunotherapy Platform Tier 1, Tier 2, and Tier 3
4 Cell Immunotherapy Platform Market by Type
- 4.1 Global Cell Immunotherapy Platform Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Cell Immunotherapy Platform Market Size by Type (2021-2032)
- 4.3 Global Cell Immunotherapy Platform Market Size Share by Type (2021-2032)
5 Cell Immunotherapy Platform Market by Application
- 5.1 Global Cell Immunotherapy Platform Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Cell Immunotherapy Platform Market Size by Application (2021-2032)
- 5.3 Global Cell Immunotherapy Platform Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Kite Pharma
- 6.1.1 Kite Pharma Company Information
- 6.1.2 Kite Pharma Business Overview
- 6.1.3 Kite Pharma Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Kite Pharma Cell Immunotherapy Platform Product Portfolio
- 6.1.5 Kite Pharma Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Company Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Novartis Cell Immunotherapy Platform Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Bristol Myers Squibb
- 6.3.1 Bristol Myers Squibb Company Information
- 6.3.2 Bristol Myers Squibb Business Overview
- 6.3.3 Bristol Myers Squibb Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Bristol Myers Squibb Cell Immunotherapy Platform Product Portfolio
- 6.3.5 Bristol Myers Squibb Recent Developments
- 6.4 Gilead Sciences
- 6.4.1 Gilead Sciences Company Information
- 6.4.2 Gilead Sciences Business Overview
- 6.4.3 Gilead Sciences Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Gilead Sciences Cell Immunotherapy Platform Product Portfolio
- 6.4.5 Gilead Sciences Recent Developments
- 6.5 Bluebird Bio
- 6.5.1 Bluebird Bio Company Information
- 6.5.2 Bluebird Bio Business Overview
- 6.5.3 Bluebird Bio Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Bluebird Bio Cell Immunotherapy Platform Product Portfolio
- 6.5.5 Bluebird Bio Recent Developments
- 6.6 Celyad Oncology
- 6.6.1 Celyad Oncology Company Information
- 6.6.2 Celyad Oncology Business Overview
- 6.6.3 Celyad Oncology Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Celyad Oncology Cell Immunotherapy Platform Product Portfolio
- 6.6.5 Celyad Oncology Recent Developments
- 6.7 Autolus Therapeutics
- 6.7.1 Autolus Therapeutics Company Information
- 6.7.2 Autolus Therapeutics Business Overview
- 6.7.3 Autolus Therapeutics Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Autolus Therapeutics Cell Immunotherapy Platform Product Portfolio
- 6.7.5 Autolus Therapeutics Recent Developments
- 6.8 Legend Biotech
- 6.8.1 Legend Biotech Company Information
- 6.8.2 Legend Biotech Business Overview
- 6.8.3 Legend Biotech Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Legend Biotech Cell Immunotherapy Platform Product Portfolio
- 6.8.5 Legend Biotech Recent Developments
- 6.9 Celltrion
- 6.9.1 Celltrion Company Information
- 6.9.2 Celltrion Business Overview
- 6.9.3 Celltrion Cell Immunotherapy Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Celltrion Cell Immunotherapy Platform Product Portfolio
- 6.9.5 Celltrion Recent Developments
7 North America
- 7.1 North America Cell Immunotherapy Platform Market Size (2021-2032)
- 7.2 North America Cell Immunotherapy Platform Market Size by Type
- 7.2.1 North America Cell Immunotherapy Platform Market Size by Type (2021-2026)
- 7.2.2 North America Cell Immunotherapy Platform Market Size by Type (2027-2032)
- 7.2.3 North America Cell Immunotherapy Platform Market Share by Type (2021-2032)
- 7.3 North America Cell Immunotherapy Platform Market Size by Application
- 7.3.1 North America Cell Immunotherapy Platform Market Size by Application (2021-2026)
- 7.3.2 North America Cell Immunotherapy Platform Market Size by Application (2027-2032)
- 7.3.3 North America Cell Immunotherapy Platform Market Share by Application (2021-2032)
- 7.4 North America Cell Immunotherapy Platform Market Size by Country
- 7.4.1 North America Cell Immunotherapy Platform Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 7.4.3 North America Cell Immunotherapy Platform Market Size by Country (2027-2032)
- 7.4.4 North America Cell Immunotherapy Platform Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Cell Immunotherapy Platform Market Size (2021-2032)
- 8.2 Europe Cell Immunotherapy Platform Market Size by Type
- 8.2.1 Europe Cell Immunotherapy Platform Market Size by Type (2021-2026)
- 8.2.2 Europe Cell Immunotherapy Platform Market Size by Type (2027-2032)
- 8.2.3 Europe Cell Immunotherapy Platform Market Share by Type (2021-2032)
- 8.3 Europe Cell Immunotherapy Platform Market Size by Application
- 8.3.1 Europe Cell Immunotherapy Platform Market Size by Application (2021-2026)
- 8.3.2 Europe Cell Immunotherapy Platform Market Size by Application (2027-2032)
- 8.3.3 Europe Cell Immunotherapy Platform Market Share by Application (2021-2032)
- 8.4 Europe Cell Immunotherapy Platform Market Size by Country
- 8.4.1 Europe Cell Immunotherapy Platform Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 8.4.3 Europe Cell Immunotherapy Platform Market Size by Country (2027-2032)
- 8.4.4 Europe Cell Immunotherapy Platform Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Cell Immunotherapy Platform Market Size (2021-2032)
- 9.2 China Cell Immunotherapy Platform Market Size by Type
- 9.2.1 China Cell Immunotherapy Platform Market Size by Type (2021-2026)
- 9.2.2 China Cell Immunotherapy Platform Market Size by Type (2027-2032)
- 9.2.3 China Cell Immunotherapy Platform Market Share by Type (2021-2032)
- 9.3 China Cell Immunotherapy Platform Market Size by Application
- 9.3.1 China Cell Immunotherapy Platform Market Size by Application (2021-2026)
- 9.3.2 China Cell Immunotherapy Platform Market Size by Application (2027-2032)
- 9.3.3 China Cell Immunotherapy Platform Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Cell Immunotherapy Platform Market Size (2021-2032)
- 10.2 Asia Cell Immunotherapy Platform Market Size by Type
- 10.2.1 Asia Cell Immunotherapy Platform Market Size by Type (2021-2026)
- 10.2.2 Asia Cell Immunotherapy Platform Market Size by Type (2027-2032)
- 10.2.3 Asia Cell Immunotherapy Platform Market Share by Type (2021-2032)
- 10.3 Asia Cell Immunotherapy Platform Market Size by Application
- 10.3.1 Asia Cell Immunotherapy Platform Market Size by Application (2021-2026)
- 10.3.2 Asia Cell Immunotherapy Platform Market Size by Application (2027-2032)
- 10.3.3 Asia Cell Immunotherapy Platform Market Share by Application (2021-2032)
- 10.4 Asia Cell Immunotherapy Platform Market Size by Country
- 10.4.1 Asia Cell Immunotherapy Platform Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 10.4.3 Asia Cell Immunotherapy Platform Market Size by Country (2027-2032)
- 10.4.4 Asia Cell Immunotherapy Platform Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Cell Immunotherapy Platform Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Type
- 11.2.1 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Cell Immunotherapy Platform Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Application
- 11.3.1 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Cell Immunotherapy Platform Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Country
- 11.4.1 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Cell Immunotherapy Platform Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Cell Immunotherapy Platform Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst